LICENSE AGREEMENT by and between ALEXION PHARMA HOLDING on the one hand, and ARBUTUS BIOPHARMA CORPORATION and PROTIVA BIOTHERAPEUTICS INC., on the other hand Dated as of March 16, 2017License Agreement • March 22nd, 2017 • Arbutus Biopharma Corp • Pharmaceutical preparations • New York
Contract Type FiledMarch 22nd, 2017 Company Industry Jurisdiction
November 20, 2016 Douglas M. Fambrough, III Ph.D. Chief Executive Officer Dicerna Pharmaceuticals Inc.License Agreement • March 22nd, 2017 • Arbutus Biopharma Corp • Pharmaceutical preparations
Contract Type FiledMarch 22nd, 2017 Company Industry